|
Jul 28
|
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 24
|
The DoD Accelerator Managed by Accuidity Capital Management Announces a $6 Million Series A Investment in Baxter Aerospace
|
|
Jul 23
|
Baxter recalls certain Novum pumps over issues tied to 79 injuries, 2 deaths
|
|
Jul 23
|
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
|
|
Jul 22
|
Preeclampsia Drug Market Research Report 2025-2035 | Competitive Analysis of Pharming Group, AMAG Pharmaceuticals, Kyowa Kirin, and Baxter
|
|
Jul 21
|
[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Jul 21
|
3 Reasons to Avoid BAX and 1 Stock to Buy Instead
|
|
Jul 17
|
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
|
|
Jul 1
|
Wells Fargo Increases PT on The Pennant Group Stock, Keeps Equal Weight Rating
|
|
Jun 26
|
5 Must-Read Analyst Questions From Baxter’s Q1 Earnings Call
|
|
Jun 24
|
Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World
|
|
Jun 24
|
FMS Stock Likely to Gain on New Optimization Plan FME Reignite
|
|
May 15
|
BAX Q1 Earnings Call: Revenue Tops Expectations, Margins Face Tariff and Cost Pressures
|
|
May 14
|
1 Mid-Cap Stock to Target This Week and 2 to Avoid
|
|
May 12
|
3 Cash-Producing Stocks in the Doghouse
|
|
Apr 30
|
Baxter (BAX) Reports Earnings Tomorrow: What To Expect
|
|
Apr 29
|
Baxter to Present at Bank of America Securities 2025 Health Care Conference
|
|
Apr 28
|
Will BAX's Q1 Earnings Improve Following Transformation Completion?
|
|
Apr 25
|
Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
|